PHYSIOLOGICALLY BASED PHARMACOKINETIC (PBPK) MODELING OF ELAGOLIX FOR PREDICTION OF DRUG-DRUG INTERACTIONS (DDIS)

被引：0
|
作者：
Chiney, M. S. [1 ]
Polepally, A. R. [1 ]
Nader, A. M. [1 ]
Dufek, M. B. [1 ]
Klein, C. E. [1 ]
Ng, J. W. [1 ]
Shebley, M. [1 ]
机构：
[1] Abbvie, N Chicago, IL USA
来源：
CLINICAL PHARMACOLOGY & THERAPEUTICS | 2017年 / 101卷 / S1期
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
PII-022
引用
收藏
页码：S59 / S59
页数：1
相关论文
共 50 条
  • [41] Physiologically-Based Pharmacokinetic Modeling to Support the Clinical Management of Drug-Drug Interactions With Bictegravir
    Stader, Felix
    Battegay, Manuel
    Marzolini, Catia
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2021, 110 (05) : 1231 - 1239
  • [42] Physiologically Based Pharmacokinetic Modeling for Selumetinib to Evaluate Drug-Drug Interactions and Pediatric Dose Regimens
    Cohen-Rabbie, Sarit
    Zhou, Li
    Vishwanathan, Karthick
    Wild, Martin
    Xu, Sherrie
    Freshwater, Tomoko
    Jain, Lokesh
    Schalkwijk, Stein
    Tomkinson, Helen
    Zhou, Diansong
    JOURNAL OF CLINICAL PHARMACOLOGY, 2021, 61 (11): : 1493 - 1504
  • [43] Physiologically Based Pharmacokinetic Modeling of Rosuvastatin to Predict Transporter-Mediated Drug-Drug Interactions
    Hanke, Nina
    Gomez-Mantilla, Jose David
    Ishiguro, Naoki
    Stopfer, Peter
    Nock, Valerie
    PHARMACEUTICAL RESEARCH, 2021, 38 (10) : 1645 - 1661
  • [44] Application of physiologically based pharmacokinetic modeling in predicting drug-drug interactions for sarpogrelate hydrochloride in humans
    Min, Jee Sun
    Kim, Doyun
    Park, Jung Bae
    Heo, Hyunjin
    Bae, Soo Hyeon
    Seo, Jae Hong
    Oh, Euichaul
    Bae, Soo Kyung
    DRUG DESIGN DEVELOPMENT AND THERAPY, 2016, 10 : 2959 - 2972
  • [45] Prediction of Drug-Drug Interaction Potential of Tegoprazan Using Physiologically Based Pharmacokinetic Modeling and Simulation
    Yoon, Deok Yong
    Lee, SeungHwan
    Jang, In-Jin
    Kim, Myeongjoong
    Lee, Heechan
    Kim, Seokuee
    Kim, Bongtae
    Song, Geun Seog
    Rhee, Su-jin
    PHARMACEUTICS, 2021, 13 (09)
  • [46] PHYSIOLOGICALLY BASED PHARMACOKINETIC MODELING OF SARPOGRELATE AND ITS APPLICATION FOR PREDICTION OF DRUG-DRUG INTERACTION IN HUMANS
    Min, Jee Sun
    Kim, Doyun
    Park, Jung Bae
    Heo, Hyunjin
    Bae, Soo Hyeon
    Bae, Soo Kyung
    DRUG METABOLISM AND PHARMACOKINETICS, 2017, 32 (01) : S53 - S53
  • [47] Quantitative Assessment of Elagolix Enzyme-Transporter Interplay and Drug–Drug Interactions Using Physiologically Based Pharmacokinetic Modeling
    Manoj S. Chiney
    Juki Ng
    John P. Gibbs
    Mohamad Shebley
    Clinical Pharmacokinetics, 2020, 59 : 617 - 627
  • [48] QUANTITATIVE PREDICTIONS AND PHYSIOLOGICALLY BASED PHARMACOKINETIC MODELING OF DRUG-DRUG INTERACTIONS BASED ON RETROSPECTIVE LITERATURE DATA
    Zhao, Ping
    DRUG METABOLISM REVIEWS, 2015, 47 : 9 - 9
  • [49] Quantitative Prediction of Drug-Drug Interactions Involving Inhibitory Metabolites in Drug Development: How Can Physiologically Based Pharmacokinetic Modeling Help?
    Templeton, I. E.
    Chen, Y.
    Mao, J.
    Lin, J.
    Yu, H.
    Peters, S.
    Shebley, M.
    Varma, M. V.
    CPT-PHARMACOMETRICS & SYSTEMS PHARMACOLOGY, 2016, 5 (10): : 505 - 515
  • [50] APPLICATION OF PBPK (SIMCYP®) MODELING FOR THE PREDICTION OF TOFACITINIB CLINICAL DRUG-DRUG INTERACTIONS
    Tse, S.
    Dowty, M.
    Menon, S.
    Gupta, P.
    Krishnaswami, S.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2016, 99 : S59 - S59
12345